Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901974796> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2901974796 abstract "Introduction Our case highlights the challenge in differentiating between hypereosinophilic syndrome (HES) and eosinophilia exacerbating atopic disease. Case Description A 29-year-old woman presents with dyspnea, dysphagia, urticaria and angioedema after childbirth. Evaluation revealed an eosinophil count of 3800/mcL. Infectious, cardiac, and chest imaging studies were normal. Lung function demonstrated FEV1/FVC at 0.85. Bronchial challenge with methacholine was positive. Bone marrow was normocellular with eosinophilia without evidence of PDGFRA, CHIC2, and FIP1L1 rearrangement. Upper endoscopy demonstrated esophageal eosinophilia. She improved on prednisone 40 mg daily, mometasone-formoterol, and montelukast. Dysphagia improved after esophageal dilation. Eosinophil counts remained elevated at 1500/mcL, with difficulty tapering prednisone due to dyspnea. She started interferon-alpha and continued prednisone 20 mg daily for 6 years with significant weight gain. She presented to our center and started mycophenolate-mofetil, discontinued interferon-alpha, and tapered prednisone to 5 mg daily. She then started mepolizumab and stopped prednisone. Six months later she developed dyspnea and urticaria. She switched to omalizumab with improvement and is stable on omalizumab, mycophenolate-mofetil, mometasone-formoterol, and montelukast. Discussion Asthma endotyping prompts checking eosinophil counts to assess for potential benefit with anti-IL5 therapy. Recent data demonstrates mepolizumab improves glucocorticoid sensitive HES, yet our patient responded better to omalizumab. The different biologics can help delineate the differential pathophysiology behind a patient's clinical presentation. Given the emerging overlap in therapeutic management, our case emphasizes the importance to shift the paradigm of understanding eosinophilic inflammation as a spectrum of disease rather than isolated entities, in consideration of both biologic and immune modulating medications." @default.
- W2901974796 created "2018-11-29" @default.
- W2901974796 creator A5021909985 @default.
- W2901974796 creator A5052192888 @default.
- W2901974796 date "2018-11-01" @default.
- W2901974796 modified "2023-09-27" @default.
- W2901974796 title "DYSPNEA, DYSPHAGIA, AND URTICARIA WITH ANGIOEDEMA AFTER CHILDBIRTH" @default.
- W2901974796 doi "https://doi.org/10.1016/j.anai.2018.09.407" @default.
- W2901974796 hasPublicationYear "2018" @default.
- W2901974796 type Work @default.
- W2901974796 sameAs 2901974796 @default.
- W2901974796 citedByCount "0" @default.
- W2901974796 crossrefType "journal-article" @default.
- W2901974796 hasAuthorship W2901974796A5021909985 @default.
- W2901974796 hasAuthorship W2901974796A5052192888 @default.
- W2901974796 hasConcept C126322002 @default.
- W2901974796 hasConcept C141071460 @default.
- W2901974796 hasConcept C141105273 @default.
- W2901974796 hasConcept C159654299 @default.
- W2901974796 hasConcept C16005928 @default.
- W2901974796 hasConcept C203014093 @default.
- W2901974796 hasConcept C2776042228 @default.
- W2901974796 hasConcept C2777014526 @default.
- W2901974796 hasConcept C2777037409 @default.
- W2901974796 hasConcept C2777129736 @default.
- W2901974796 hasConcept C2777683962 @default.
- W2901974796 hasConcept C2777832160 @default.
- W2901974796 hasConcept C2777995640 @default.
- W2901974796 hasConcept C2778564945 @default.
- W2901974796 hasConcept C2778720950 @default.
- W2901974796 hasConcept C2779134260 @default.
- W2901974796 hasConcept C2780596822 @default.
- W2901974796 hasConcept C2781065132 @default.
- W2901974796 hasConcept C43270747 @default.
- W2901974796 hasConcept C71924100 @default.
- W2901974796 hasConcept C90924648 @default.
- W2901974796 hasConceptScore W2901974796C126322002 @default.
- W2901974796 hasConceptScore W2901974796C141071460 @default.
- W2901974796 hasConceptScore W2901974796C141105273 @default.
- W2901974796 hasConceptScore W2901974796C159654299 @default.
- W2901974796 hasConceptScore W2901974796C16005928 @default.
- W2901974796 hasConceptScore W2901974796C203014093 @default.
- W2901974796 hasConceptScore W2901974796C2776042228 @default.
- W2901974796 hasConceptScore W2901974796C2777014526 @default.
- W2901974796 hasConceptScore W2901974796C2777037409 @default.
- W2901974796 hasConceptScore W2901974796C2777129736 @default.
- W2901974796 hasConceptScore W2901974796C2777683962 @default.
- W2901974796 hasConceptScore W2901974796C2777832160 @default.
- W2901974796 hasConceptScore W2901974796C2777995640 @default.
- W2901974796 hasConceptScore W2901974796C2778564945 @default.
- W2901974796 hasConceptScore W2901974796C2778720950 @default.
- W2901974796 hasConceptScore W2901974796C2779134260 @default.
- W2901974796 hasConceptScore W2901974796C2780596822 @default.
- W2901974796 hasConceptScore W2901974796C2781065132 @default.
- W2901974796 hasConceptScore W2901974796C43270747 @default.
- W2901974796 hasConceptScore W2901974796C71924100 @default.
- W2901974796 hasConceptScore W2901974796C90924648 @default.
- W2901974796 hasLocation W29019747961 @default.
- W2901974796 hasOpenAccess W2901974796 @default.
- W2901974796 hasPrimaryLocation W29019747961 @default.
- W2901974796 hasRelatedWork W1502770198 @default.
- W2901974796 hasRelatedWork W2070296638 @default.
- W2901974796 hasRelatedWork W2115407619 @default.
- W2901974796 hasRelatedWork W2123896274 @default.
- W2901974796 hasRelatedWork W2341239715 @default.
- W2901974796 hasRelatedWork W2416851213 @default.
- W2901974796 hasRelatedWork W2600108464 @default.
- W2901974796 hasRelatedWork W2886965943 @default.
- W2901974796 hasRelatedWork W2901974796 @default.
- W2901974796 hasRelatedWork W3192688925 @default.
- W2901974796 isParatext "false" @default.
- W2901974796 isRetracted "false" @default.
- W2901974796 magId "2901974796" @default.
- W2901974796 workType "article" @default.